ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Cervix Moves Significantly During Radiation for Cancer

February 27, 2009

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007